Abel Hall LLC’s SBC Medical Group SBC Stock Holding History

Abel Hall LLC’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,607	Closed	-$32.7K	–	1058
2026 Q2	$32.7K	Buy	+10,607	New	+$36K	0.01%	921

Other funds holding SBC

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Williams & Novak Westlake Village, California $169M AUM 17.63% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Covestor London, United Kingdom $157M AUM 35.87% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Abel Hall LLC's SBC Position: Q3 2026 in Review

Abel Hall LLC sold out of SBC Medical Group (SBC) in Q3 2026, closing a stake of 10,607 shares — an estimated $32.7K sold.

Abel Hall LLC first reported a position in SBC in Q2 2026 and held it in 1 quarter. The position peaked at $32.7K in Q2 2026. 12 funds tracked by Wall St. Rank hold SBC as of Q3 2026.

Abel Hall LLC reported no remaining SBC Medical Group position as of Q3 2026 after selling out during the quarter.
Abel Hall LLC sold 10,607 SBC Medical Group shares in Q3 2026, an estimated $32.7K.
Abel Hall LLC first reported a position in SBC Medical Group in Q2 2026 and held it in 1 quarter.
Abel Hall LLC's SBC Medical Group position peaked at $32.7K in Q2 2026.
12 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.